Penumbra Inc (PEN) CEO Adam Elsesser Sold $1.4 million of Shares

Author's Avatar
Mar 12, 2020
Article's Main Image

CEO of Penumbra Inc (30-Year Financial, Insider Trades) Adam Elsesser (insider trades) sold 8,000 shares of PEN on 03/09/2020 at an average price of $172.01 a share. The total sale was $1.4 million.

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra Inc has a market cap of $6.2 billion; its shares were traded at around $176.86 with a P/E ratio of 131.01 and P/S ratio of 11.71. Penumbra Inc had annual average EBITDA growth of 56.90% over the past five years. GuruFocus has detected 1 severe warning sign with Penumbra Inc. .

CEO Recent Trades:

  • CEO Adam Elsesser sold 8,000 shares of PEN stock on 03/09/2020 at the average price of $172.01. The price of the stock has increased by 2.82% since.

Directors and Officers Recent Trades:

  • Director Don W. Kassing sold 304 shares of PEN stock on 02/24/2020 at the average price of $186.3. The price of the stock has decreased by 5.07% since.
  • President Sridhar Kosaraju sold 2,500 shares of PEN stock on 02/18/2020 at the average price of $190.7. The price of the stock has decreased by 7.26% since.
  • EVP and Chief Business Officer Lynn Rothman sold 5,000 shares of PEN stock on 02/11/2020 at the average price of $185.25. The price of the stock has decreased by 4.53% since.
  • Chief Innovator Arani Bose sold 10,000 shares of PEN stock on 02/11/2020 at the average price of $185.3. The price of the stock has decreased by 4.55% since.

For the complete insider trading history of PEN, click here

.